| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001755 | Neural crest cell migration | Decreases phenotype | PMID:26238599 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:23145070 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:36411272 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:36411272 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:36411272 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:26989453 |
| GO:0006754 | Atp biosynthetic process | Affects phenotype | PMID:35435491 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:23145070; PMID:24942245 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:27660204 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:30503815 |
| GO:0007268 | Chemical synaptic transmission | Affects phenotype | PMID:24675092 |
| GO:0007399 | Nervous system development | Decreases phenotype | PMID:24675092 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:23145070; PMID:24942245 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29555536 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:27015953 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:30503815 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:36411272 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:36411272 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:24675092 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:36411272 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:27660204 |
| GO:0043967 | Histone h4 acetylation | Decreases phenotype | PMID:27660204 |
| GO:0044060 | Regulation of endocrine process | Affects phenotype | PMID:24675092 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:38325586 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:38325586 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:23145070; PMID:24942245 |
| GO:0046902 | Regulation of mitochondrial membrane permeability | Affects phenotype | PMID:24942245 |
| GO:0048666 | Neuron development | Affects phenotype | PMID:24675092 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:24675092 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:36411272; PMID:38325586 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.